Picture of InnovAge Holding logo

INNV — InnovAge Holding News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

InnovAge Q1 revenue up 15.1%, beats expectations

Overview

InnovAge fiscal Q1 revenue grows 15.1%, beating analyst expectations

Company reports net income of $7.7 mln, reversing a loss from last year

Adjusted EBITDA for fiscal Q1 rises significantly

Outlook

InnovAge projects fiscal 2026 revenue between $900 mln and $950 mln

Company expects fiscal 2026 Adjusted EBITDA of $56 mln to $65 mln

InnovAge anticipates participant census of 7,900 to 8,100 in fiscal 2026

Result Drivers

PARTICIPANT CENSUS - InnovAge reports increased participant census, contributing to revenue growth

INVESTMENTS IN TECHNOLOGY - Continued investment in technology supports sustainable growth, per CEO Patrick Blair

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 RevenueBeat$236.10 mln$226.60 mln (3 Analysts)
Q1 EPS$0.06
Q1 Net Income$7.70 mln
Analyst Coverage The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell" Wall Street's median 12-month price target for InnovAge Holding Corp is $6.00, about 21% above its November 3 closing price of $4.74 The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 66 three months ago Press Release: ID:nGNX19SZSF For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on InnovAge Holding

See all news